▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Keith Speights

TMFFishBiz

Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, and marijuana. Prior to The Motley Fool, Speights was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.

Recent Articles by Keith Speights

Money raining down on woman

Aug 16, 2020 by Keith Speights

Investing $5,000 in These 3 Popular Robinhood Stocks Could Make You a Fortune

Following the crowd doesn't always pay off. But it probably will with these three hot stocks.

Dividends bag under umbrella

Aug 16, 2020 by Keith Speights

3 Dividend Stocks Yielding More Than 4% That Are Safe Buys Right Now

You can sleep tight while the dividends pour in with these three stocks.

Moneybags

Aug 15, 2020 by Keith Speights

Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?

Here's how it could happen.

Hand with dollar sign

Aug 15, 2020 by Keith Speights

If You Invested $1,000 in Novavax's IPO, This Is How Much Money You'd Have Now

It's not as much as you might think.

CBD oil bottle next to hemp

Aug 14, 2020 by Keith Speights

Why Charlotte's Web Holdings Stock Jumped Today

Investors appear to be getting more optimistic about the company's upcoming Q2 update.

Man wearing nebulizer mask with thumb up

Aug 14, 2020 by Keith Speights

Why Verona Pharma Stock Is Vaulting Higher Today

The small drugmaker reported good news about new clinical studies for its lead pipeline candidate.

Smiling people with thumbs up

Aug 14, 2020 by Keith Speights

Why Mesoblast Stock Is Skyrocketing Today

The small biotech received good news from an FDA advisory committee.

Magnifying glass, coronavirus, stock chart

Aug 14, 2020 by Keith Speights

Why Co-Diagnostics Stock Is Tanking Today

Investors weren't happy with the molecular diagnostics company's Q2 results.

Hands holding two marijuana leaves

Aug 14, 2020 by Keith Speights

Better Cannabis Stock: Cronos Group vs. Tilray

Both of these Canadian pot stocks are losers so far in 2020, but one seems better positioned to return to the winners' column.

Jigsaw puzzle pieces with light bulb and dollar sign

Aug 14, 2020 by Keith Speights

Is AstraZeneca Stock a Buy?

The drugmaker's current lineup, pipeline, and dividend make the question an easy one to answer.

Woman scientist looking through microscope

Aug 14, 2020 by Keith Speights

COVID-19 Pandemic Wreaks Havoc on Myriad Genetics' Fiscal Q4 Results

But there were a few encouraging signs for the molecular-diagnostics company.

Clear dental aligner

Aug 13, 2020 by Keith Speights

Why SmileDirectClub Stock Is Sinking Today

Mixed Q2 results and an uncertain outlook due to COVID-19 are weighing on the teledentistry stock.

Hand holding clear aligner

Aug 13, 2020 by Keith Speights

Here's Why SmileDirectClub Missed Wall Street's Q2 Earnings Estimates

And how the company managed to beat analysts' revenue estimates despite a 45% sales plunge.

Hand with DNA helix image

Aug 12, 2020 by Keith Speights

Why Pacific Biosciences of California Shares Are Soaring Today

Investors liked the pricing of the company's secondary stock offering.

Holding syringe and vaccine bottle

Aug 12, 2020 by Keith Speights

Why Inovio Stock Is Sinking Again Today

Questions about its coronavirus vaccine candidate continue to weigh on the biotech stock.

Doctor holding COVID-19 vaccine with thumb up

Aug 9, 2020 by Keith Speights

This Could Be the Ace in the Hole for Johnson & Johnson's COVID-19 Vaccine

J&J is behind in the race to develop a COVID-19 vaccine. But there's one thing that could make it a come-from-behind winner.

Arrows missing target

Aug 9, 2020 by Keith Speights

3 Large-Cap Stocks That Should Soar If Coronavirus Vaccines Flop

No one wants COVID-19 vaccines to fail. But if you want to hedge for the possibility, check out these solid stocks.

3 cannabis leaves

Aug 9, 2020 by Keith Speights

3 Most Popular Marijuana Stocks on Robinhood: Are They Buys?

There's been some shifting positions in recent months among Robinhood investors' favorite pot stocks.

Dollar sign with coronavirus

Aug 9, 2020 by Keith Speights

3 Top Coronavirus Stocks to Buy in August

Two big drugmakers and one small biotech appear to be great picks right now.

Businessman drawing dollar sign and question mark

Aug 9, 2020 by Keith Speights

If You'd Invested $1,000 in Pfizer During the Last Recession, This Is How Much You Would Have Today

Exactly when you invested makes a big difference.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services